AEON Biopharma, Inc.
AEONNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for AEON. That does not mean none is planned.
Get an email about AEON's next catalysts
Track AEON Biopharma (AEON) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
AEON Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.10 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ABP-450 | Phase 2 | Cervical Dystonia | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in AEON Biopharma, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in AEON Biopharma, Inc.'s (AEON) pipeline across Phase 2. Its lead program is ABP-450 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is AEON Biopharma, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for AEON Biopharma, Inc. (AEON) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AEON biotech catalysts?→
Add AEON to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AEON Biopharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.